$1.2B in vet tech funding last year. Over 1,100 startups globally. But most of them get acquired before they ever prove they can stand alone. So where does that leave the mid-size animal health companies watching from the sidelines? On April 21, Joseph Harvey, Head of Animal Health at S&P Global, joins Prelude CEO Tommy Buchanan Jackson to break down which startup categories have real traction, how the Big 5 are responding, and what companies at every level should be paying attention to. Joseph has spent 14 years tracking deal flow, profiling startups, and interviewing both incumbent executives and early-stage founders. He sees the full picture. Register for the live session: https://lnkd.in/gggaq37A Can't make it live? Register anyway and we'll send you the recording afterward. #AnimalHealth #AnimalHealthRnD #VeterinaryResearch
I like this idea 💡
The high volume of vet tech acquisitions signals a dynamic market. Strategic analysis of startup traction and incumbent responses is crucial.